PRO-DEX, INC. Noncash or Part Noncash Acquisition, Debt Assumed
PRO-DEX, INC. (PDEX) reported Noncash or Part Noncash Acquisition, Debt Assumed of $570.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionDebtAssumed1 · last filed 2026-09-03
- PRO-DEX, INC. noncash or part noncash acquisition, debt assumed for fiscal 2026 was $570.00K.
- PRO-DEX, INC. noncash or part noncash acquisition, debt assumed for fiscal 2024 was $8.00K.
- PRO-DEX, INC. noncash or part noncash acquisition, debt assumed for fiscal 2015 was $100.00K.
| Period end | Noncash or Part Noncash Acquisition, Debt Assumed 12 month |
|---|---|
| 2026-06-30 | $570.00K 10-K · filed 2026-09-03 |
| 2024-06-30 | $8.00K 10-K · filed 2025-09-04 |
| 2015-06-30 | $100.00K 10-K · filed 2016-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |